本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kestra Medical Technologies Inc

24.71
+0.64502.68%
成交量:48.25萬
成交額:1,133.05萬
市值:14.42億
市盈率:-10.17
高:24.71
開:21.82
低:21.56
收:24.06
52周最高:30.00
52周最低:17.34
股本:5,834.91萬
流通股本:3,073.73萬
量比:2.80
換手率:1.57%
股息:- -
股息率:- -
每股收益(TTM):-2.4290
每股收益(LYR):-2.4290
淨資產收益率:-56.60%
總資產收益率:-25.75%
市淨率:5.55
市盈率(LYR):-10.17

資料載入中...

2026/07/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/14

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/07/14

重要事件披露

Form 8-K - Current report
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/08

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/18

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/03/17

重要事件披露

Form 8-K - Current report